Spyridon Gennatas

15PUBLICATIONS
115CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseasePredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 26, 2025
A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices.

Joshua Walker, Amsajini Ravinthiranathan, Athanasios Diamantopoulos

|Sep 13, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.

Umair Mahmood, Eleni Josephides, Meenali Chitnis

|Apr 29, 2023
Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use.

Anne-Rose W Schut, Leanne E de Bruin, Belle H de Rooij

|Dec 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World Study

Daniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda

|Aug 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.

Oskar Wysocki, Cong Zhou, Jacobo Rogado

|May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.

Rebecca J Lee, Oskar Wysocki, Cong Zhou

Pageof 3

Frequent Collaborators

7 joint publications

Robin L Jones

4 joint publications

Emma Lidington

4 joint publications

Olga Husson

3 joint publications

Alexandros Georgiou